Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Journal of Virology|November 2, 2012
Inefficient vaginal transmission of tenofovir-resistant HIV-1Morgan Chateau, Michael D Swanson, J Victor GarciaFrontiers in Immunology|August 15, 2022
Immunogenicity Risk Assessment of Spontaneously Occurring Therapeutic Monoclonal Antibody AggregatesMichael D Swanson, Shantel Rios, Sarita Mittal, et al.The Journal of Biological Chemistry|January 19, 2010
A lectin isolated from bananas is a potent inhibitor of HIV replicationMichael D Swanson, Harry C Winter, Irwin J Goldstein, et al.Plos One|March 26, 2013
Rectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized miceMorgan L Chateau, Paul W Denton, Michael D Swanson, et al.Antimicrobial Agents and Chemotherapy|September 23, 2015
Role of Semen on Vaginal HIV-1 Transmission and Maraviroc ProtectionOlivia D Council, Michael D Swanson, Rae Ann Spagnuolo, et al.The AAPS Journal|May 16, 2025
Short-Term Immunosuppression in Rats Induces Prolonged Immune Tolerance Towards a Human Monoclonal Antibody, ErenumabParidhi Gupta, Ashish Srivastava, Josiah T Ryman, et al.Plos Pathogens|June 28, 2012
Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized miceAngela Wahl, Michael D Swanson, Tomonori Nochi, et al.AIDS Research and Human Retroviruses|May 22, 2012
Combinations of griffithsin with other carbohydrate-binding agents demonstrate superior activity against HIV Type 1, HIV Type 2, and selected carbohydrate-binding agent-resistant HIV Type 1 strainsGeoffrey Férir, Dana Huskens, Kenneth E Palmer, et al.Journal of Virology|May 18, 2012
Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1Marta J Gonzalez-Hernandez, Michael D Swanson, Rafael Contreras-Galindo, et al.The Journal of Antimicrobial Chemotherapy|March 23, 2016
A long-acting formulation of the integrase inhibitor raltegravir protects humanized BLT mice from repeated high-dose vaginal HIV challengesMartina Kovarova, Michael D Swanson, Rosa I Sanchez, et al.Pageof 3